Colorado Prescription Drugs Affordability Board Risks
Échec de l'ajout au panier.
Échec de l'ajout à la liste d'envies.
Échec de la suppression de la liste d’envies.
Échec du suivi du balado
Ne plus suivre le balado a échoué
Colorado Prescription Drugs Affordability Board Risks
-
Narrateur(s):
-
Auteur(s):
À propos de cet audio
In this episode, hosts Crystal Weaver and Shabbir Imber Safdar dive into the rapidly evolving world of Prescription Drug Affordability Boards and upper payment limits—two key policy tools designed to tackle rising drug costs at the state level.
With special guests Emily Zadvorny, PharmD, BCPS, Executive Director of the Colorado Pharmacists Society, and Bridget Dandaraw-Seritt, patient advocate and Founder of Advocates for Compassionate Therapy Now, the conversation unpacks the real-world impacts of PDAB policies on pharmacies, health systems, and—most critically—patients.
From legal battles in Colorado to the concern over whether cost savings actually reach patients, this episode explores whether these efforts are targeting the right pain points or simply shifting the burden downstream.